NRx Announces Data-Sharing Agreement with Columbia University for Results from IV Ketamine Trial December 19, 2023
NRx Pharmaceuticals Founder Jonathan Javitt Discusses Company’s Mission, Pipeline in Nasdaq Interview December 6, 2023
